Oculis’ eye drops for diabetic macular edema flunk Phase 3 test

Diabetic macular edema eye drop from Oculis fails to meet primary endpoint

Oculis will not pursue FDA approval for OCS-01, an eye drop for diabetic macular edema, after it failed to meet the primary endpoint in a phase 3 program, according to a press release.The DIAMOND program included two…